Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 35001 - 35025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dinitrochlorobenzene	Investigational	BCLAF1	9774	downregulated	Dinitrochlorobenzene results in decreased expression of BCLAF1 mRNA	6q23.3	A22388
Dinitrochlorobenzene	Investigational	BMP6	654	upregulated	Dinitrochlorobenzene results in increased expression of BMP6 mRNA	6p24.3	A22388
Dinitrochlorobenzene	Investigational	BTG1	694	upregulated	Dinitrochlorobenzene results in increased expression of BTG1 mRNA	12q21.33	A22388
Dinitrochlorobenzene	Investigational	BUB1	699	downregulated	Dinitrochlorobenzene results in decreased expression of BUB1 mRNA	2q13	A22388
Dinitrochlorobenzene	Investigational	CA2	760	downregulated	Dinitrochlorobenzene results in decreased expression of CA2 mRNA	8q21.2	A22388
Dinitrochlorobenzene	Investigational	CALCA	796	upregulated	Dinitrochlorobenzene results in increased expression of CALCA mRNA	11p15.2	A22391
Dinitrochlorobenzene	Investigational	CALCRL	10203	upregulated	Dinitrochlorobenzene results in increased expression of CALCRL mRNA	2q32.1	A22388
Dinitrochlorobenzene	Investigational	CAT	847	upregulated	Dinitrochlorobenzene results in increased expression of CAT mRNA	11p13	A21074
Dinitrochlorobenzene	Investigational	CCL2	6347	downregulated	Dinitrochlorobenzene results in decreased expression of CCL2 mRNA	17q12	A22388 A21532
Dinitrochlorobenzene	Investigational	CCL2	6347	upregulated	Dinitrochlorobenzene results in increased expression of CCL2 mRNA	17q12	A22392
Dinitrochlorobenzene	Investigational	CCL3	6348	upregulated	Dinitrochlorobenzene results in increased expression of CCL3 mRNA	17q12	A22392 A22391
Dinitrochlorobenzene	Investigational	CCL4	6351	upregulated	Dinitrochlorobenzene results in increased expression of CCL4 mRNA	17q12	A22392 A22389 A22391
Dinitrochlorobenzene	Investigational	CCR2	729230	downregulated	Dinitrochlorobenzene results in decreased expression of CCR2 mRNA	3p21.31	A22388 A22393
Dinitrochlorobenzene	Investigational	CCR2	729230	upregulated	Dinitrochlorobenzene results in increased expression of CCR2 mRNA	3p21.31	A21532
Dinitrochlorobenzene	Investigational	CCR5	1234	upregulated	Dinitrochlorobenzene results in increased expression of CCR5 mRNA	3p21.31	A21532
Dinitrochlorobenzene	Investigational	CCR7	1236	downregulated	Dinitrochlorobenzene results in decreased expression of CCR7 mRNA	17q21.2	A21532
Dinitrochlorobenzene	Investigational	CCR7	1236	upregulated	Dinitrochlorobenzene results in increased expression of CCR7 mRNA	17q21.2	A22394 A22388 A22393
Dinitrochlorobenzene	Investigational	CD36	948	downregulated	Dinitrochlorobenzene results in decreased expression of CD36 mRNA	7q21.11	A22388
Dinitrochlorobenzene	Investigational	CD86	942	upregulated	Dinitrochlorobenzene results in increased expression of CD86 mRNA	3q13.33	A22388
Dinitrochlorobenzene	Investigational	CDH8	1006	downregulated	Dinitrochlorobenzene results in decreased expression of CDH8 mRNA	16q21	A22388
Dinitrochlorobenzene	Investigational	CDK12	51755	downregulated	Dinitrochlorobenzene results in decreased expression of CDK12 mRNA	17q12	A22390
Dinitrochlorobenzene	Investigational	CDKN1A	1026	upregulated	Dinitrochlorobenzene results in increased expression of CDKN1A mRNA	6p21.2	A22389
Dinitrochlorobenzene	Investigational	CDKN1C	1028	upregulated	Dinitrochlorobenzene results in increased expression of CDKN1C mRNA	11p15.4	A22391
Dinitrochlorobenzene	Investigational	CERKL	375298	downregulated	Dinitrochlorobenzene results in decreased expression of CERKL mRNA	2q31.3	A22388
Dinitrochlorobenzene	Investigational	CES1	1066	upregulated	Dinitrochlorobenzene results in increased expression of CES1 mRNA	16q12.2	A22395

Displaying entries 35001 - 35025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability